During the past decade, Cambridge Medical Center conducted 109 clinical trials. In the 10-year time frame, 109 clinical trials started and 7 clinical trials were completed, i.e. on average, 6.4% percent of trials that started reached the finish line to date. In the past 5 years, 65 clinical trials started and 7 clinical trials were completed. i.e. 10.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cambridge Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 45 trials, followed by "Alliance for Clinical Trials in Oncology" with 20 trials sponsored, "SWOG Cancer Research Network" with 16 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored and "NRG Oncology" with 15 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cambridge Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 63 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Cambridge Medical Center" are "Stage IV Lung Cancer AJCC v8" (9 trials), "Invasive Breast Carcinoma" (7 trials), "Stage IVA Lung Cancer AJCC v8" (6 trials), "Stage IVB Lung Cancer AJCC v8" (6 trials) and "Anatomic Stage II Breast Cancer AJCC v8" (5 trials). Many other conditions were trialed in "Cambridge Medical Center" in a lesser frequency.

Most popular intervention types in "Cambridge Medical Center" are "Drug" (78 trials), "Other" (58 trials), "Biological" (44 trials), "Procedure" (39 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (30 trials), "Questionnaire Administration" (26 trials), "Biospecimen Collection" (25 trials), "Computed Tomography" (22 trials) and "Nivolumab" (16 trials). Other intervention names were less common.

The vast majority of trials in "Cambridge Medical Center" are 96 trials for "All" genders, 11 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Cambridge Medical Center". undefined are not yet recruiting, 53 are recruiting, 46 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Cambridge Medical Center, 5 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Cambridge Medical Center, 0 "Phase 1" clinical trials were conducted, 56 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".